Table 1. Summary of biological therapies of inflammatory bowel disease. Target or supplement Agent name (nature) Application Usage Ref. Anti-TNF Infliximab (mAb) UC, CD, approved by US FDA iv.
Objective This study examined the safety and efficacy of biological agents, especially tumour necrosis factor (TNF) inhibitors, for HIV-positive rheumatology patients refractory to standard therapy.
Biological therapy is a type of therapeutic treatment. The agents used for biological therapy are designed to specifically target a biological phenomenon, gene, protein, or group of genes or ...
Revolutionary research shows statins combined with new PIN1 inhibitors could transform bladder cancer treatment, offering hope to thousands of patients.